MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
50.67%
Quick Ratio
50.67%
Cash Ratio
1.32%
Debt to Asset Ratio
16.59%
Unit: Dollar
Assets Breakdown
    • Digital assets, at fair value
    • Restricted cash
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Convertible notes, net
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
278,371
979,534
1,636,655
6,986,617
Restricted cash
8,000,000
8,000,000
8,000,000
-
Short term investments
-
1,500,000
2,000,000
-
Prepaid expenses
2,235,996
2,625,169
2,298,704
2,099,491
Due from related parties
115,570
-
-
-
Other current assets
48,501
48,500
48,500
-
Total current assets
10,678,438
13,153,203
13,983,859
9,086,108
Digital assets, at fair value
116,737,168
127,815,173
149,885,371
-
Long-term portion of prepaid expenses
-
22,410
75,485
129,740
Operating lease right of use asset, net
156,162
171,779
187,395
-
Property and equipment, at cost
66,727
-
-
-
Less accumulated depreciation
14,798
-
-
-
Property and equipment, net
51,929
56,592
51,626
34,188
Total assets
127,623,697
141,219,157
164,183,736
9,250,036
Accounts payable and accrued expenses
3,221,643
2,978,190
918,649
-
Accrued offering costs
780,000
575,000
500,000
-
Accounts payable and accrued expenses
-
-
-
567,633
Accrued interest
1,200,000
-
-
-
Accrued interest - related party
-
36,339
27,952
21,651
Accrued interest related party
40,350
-
-
-
Advance payable to related party
12,000
12,000
12,000
100
Notes payable - related party
500,100
500,100
500,100
500,000
Notes payable, net
5,000,000
920,000
-
-
Derivative liability
1,352,641
1,568,634
1,616,913
-
Convertible notes, net
8,907,026
7,942,281
7,091,263
-
Operating lease liability
59,523
52,339
39,578
-
Total current liabilities
21,073,283
14,584,883
10,706,455
1,089,384
Long-term portion of operating lease liability
101,873
118,815
129,454
-
Total liabilities
21,175,156
14,703,698
10,835,909
1,089,384
Preferred stock, par value 0.001, 10,000,000 shares authorized 747,702 shares issued and outstanding as of june 30, 2026 and december 31, 2025
748
74,770
74,770
-
Common stock, par value 0.001, 100,000,000 shares authorized 1,509,118 and 1,257,598 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
1,509
125,760
125,760
125,760
Common shares to be issued
3,636,262
8,113,318
-
-
Additional paid-in capital
168,436,065
163,654,524
163,540,358
17,272,661
Accumulated deficit
-65,626,043
-45,452,913
-10,393,061
-9,237,769
Total shareholders equity (deficit)
106,448,541
126,515,459
153,347,827
8,160,652
Total liabilities and shareholders equity
127,623,697
141,219,157
164,183,736
9,250,036
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Restricted cash$8,000,000 Prepaid expenses$2,235,996 (38.52%↑ Y/Y)Cash and cashequivalents$278,371 (-96.81%↓ Y/Y)Due from relatedparties$115,570 Other current assets$48,501 Property and equipment,at cost$66,727 Digital assets, at fairvalue$116,737,168 Total current assets$10,678,438 (3.18%↑ Y/Y)Operating lease right ofuse asset, net$156,162 Property and equipment,net$51,929 (295.29%↑ Y/Y)Less accumulateddepreciation$14,798 Total assets$127,623,697 (1110.08%↑ Y/Y)Total liabilities andshareholders equity$127,623,697 (1110.08%↑ Y/Y)Total shareholdersequity (deficit)$106,448,541 (993.16%↑ Y/Y)Total liabilities$21,175,156 (2517.44%↑ Y/Y)Accumulated deficit-$65,626,043 (-780.12%↓ Y/Y)Additional paid-in capital$168,436,065 (886.83%↑ Y/Y)Total currentliabilities$21,073,283 (2504.85%↑ Y/Y)Long-term portion ofoperating lease liability$101,873 Common shares to beissued$3,636,262 Common stock, par value0.001, 100,000,000...$1,509 (-98.80%↓ Y/Y)Preferred stock, par value0.001, 10,000,000...$748 Convertible notes, net$8,907,026 Notes payable, net$5,000,000 Accounts payable andaccrued expenses$3,221,643 (2604.13%↑ Y/Y)Derivative liability$1,352,641 Accrued interest$1,200,000 Accrued offering costs$780,000 Notes payable -related party$500,100 (0.02%↑ Y/Y)Operating lease liability$59,523 Accrued interest related party$40,350 Advance payable torelated party$12,000 (11900.00%↑ Y/Y)

Apimeds Pharmaceuticals US, Inc. (APUS)

Apimeds Pharmaceuticals US, Inc. (APUS)